(S)-N-Methyl-2-(7-methyl-4-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-3-yl)acetamide

ID: ALA4483495

PubChem CID: 147930449

Max Phase: Preclinical

Molecular Formula: C21H21N3O5

Molecular Weight: 395.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC(=O)C[C@H]1COc2cc(C)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2

Standard InChI:  InChI=1S/C21H21N3O5/c1-12-3-5-16-18(7-12)28-10-14(9-19(25)22-2)24(16)21(27)13-4-6-17-15(8-13)23-20(26)11-29-17/h3-8,14H,9-11H2,1-2H3,(H,22,25)(H,23,26)/t14-/m0/s1

Standard InChI Key:  IJTNKDPWHRABRX-AWEZNQCLSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   30.1150  -18.5188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1138  -19.3384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8219  -19.7473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8201  -18.1100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5287  -18.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5275  -19.3359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2337  -19.7449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9456  -19.3379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9468  -18.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2361  -18.1036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.2315  -20.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5226  -20.9687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9380  -20.9727    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.8180  -20.5575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1096  -20.9634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5239  -21.7836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8185  -22.1919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1105  -21.7798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4036  -22.1847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3985  -23.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1065  -23.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8195  -23.0088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.1028  -24.2324    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6522  -19.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3610  -19.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0676  -19.7524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3633  -18.5246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.7764  -19.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4072  -18.1104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  2  0
 14 15  1  0
 15 18  2  0
 17 16  2  0
 16 12  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
  8 24  1  6
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  1  0
  1 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4483495

    ---

Associated Targets(Human)

NR3C2 Tclin Mineralocorticoid receptor (2134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.42Molecular Weight (Monoisotopic): 395.1481AlogP: 1.87#Rotatable Bonds: 3
Polar Surface Area: 96.97Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.46CX Basic pKa: CX LogP: 1.09CX LogD: 1.09
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.83Np Likeness Score: -1.09

References

1. Granberg KL, Yuan ZQ, Lindmark B, Edman K, Kajanus J, Hogner A, Malmgren M, O'Mahony G, Nordqvist A, Lindberg J, Tångefjord S, Kossenjans M, Löfberg C, Brånalt J, Liu D, Selmi N, Nikitidis G, Nordberg P, Hayen A, Aagaard A, Hansson E, Hermansson M, Ivarsson I, Jansson-Löfmark R, Karlsson U, Johansson U, William-Olsson L, Hartleib-Geschwindner J, Bamberg K..  (2019)  Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.,  62  (3): [PMID:30596500] [10.1021/acs.jmedchem.8b01523]

Source